arrow
D

Donna E. Hansel

university of texas system
H指数:65
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology

可操作的转录组: 将RNA测序纳入精确肿瘤学的框架

2026-01-050
PRE
International Society of Urological Pathology Consensus Meeting 2024

国际泌尿病理学会共识会议2024

2025-12-010
PRE
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group

Gupta, S.; Hensley, P.J.; Li, R.; Choudhury, A.; Daneshmand, S.; Faltas, B.M.; Flaig, T.W.; Grass, G.D.; Grivas, P.; Hansel, D.E. 肌层浸润性膀胱癌的保膀胱策略:国际膀胱癌小组的建议。Eur. Urol. 2025, 已接受待发表。 [Google Scholar] [CrossRef]

2025-04-220
PRE
Current Reporting Trends, Practices, and Resource Utilization in Penile Cancer: A Survey among Genitourinary Pathologists
2025-03-010
PRE
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
2024-02-143
OAAI
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract
2023-12-013
PRE
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
2021-09-107
PRE
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers

泌尿生殖病理学会更新了尿路上皮癌的变异组织学分类,T1亚阶段,分子分类学和免疫疗法以及PD-L1检测的意义

2021-06-1728
PRE